Cite
MLA Citation
Alexander E Perl et al.. “Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study.” Lancet oncology, vol. 18, no. 8, n.d., pp. 1061–1075. http://access.bl.uk/ark:/81055/vdc_100049766196.0x000013